Article
E239K mutation abolishes the suppressive effects of lysine-specific demethylase 1 on migration and invasion of MCF7 cells.
Cancer science - 1 Feb 2022
Zhang Yu, Wu Tong, Zhao Bo, Liu Ziyu, Qian Rui, Zhang Jing, Shi Yueru, Wan Youzhong, Li Zhe, Hu Xin
Abstract excerpt
Lysine-specific demethylase 1 (LSD1) is an important histone demethylase that mediates epithelial to mesenchymal transition (EMT). The E239K mutation of LSD1 was identified in a luminal breast cancer patient from the COSMIC Breast Cancer dataset. To investigate the functional effects of the E239K mutation of LSD1, a stable LSD1 knockdown MCF7 cell line was generated. Rescue with WT LSD1, but not E239K mutated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
